|
G |
Ace |
angiotensin I converting enzyme |
decreases activity multiple interactions |
ISO EXP |
Ramipril results in decreased activity of ACE protein Ramipril inhibits the reaction [Doxorubicin results in increased expression of ACE mRNA] |
CTD |
PMID:3034026 PMID:10543928 PMID:36636964 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Doxorubicin results in increased expression of ACTA2 mRNA] |
CTD |
PMID:36636964 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions increases expression decreases expression |
ISO |
candesartan promotes the reaction [Ramipril results in increased expression of ADIPOQ]; Ramipril promotes the reaction [candesartan results in increased expression of ADIPOQ] Ramipril results in decreased expression of ADIPOQ |
CTD |
PMID:17483542 PMID:19059660 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Doxorubicin results in increased expression of AGTR1A mRNA] |
CTD |
PMID:36636964 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Carbon Tetrachloride results in increased expression of ALPL protein] |
CTD |
PMID:26862777 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects expression |
EXP |
Ramipril affects the expression of BAX protein |
CTD |
PMID:10728395 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
affects expression |
EXP |
Ramipril affects the expression of BCL2 protein |
CTD |
PMID:10728395 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein] |
CTD |
PMID:17703430 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] |
CTD |
PMID:26862777 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
[Simvastatin co-treated with Ramipril] results in decreased expression of CCL2 protein |
CTD |
PMID:15184351 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
EXP |
[Streptozocin co-treated with Resveratrol co-treated with Ramipril] results in decreased expression of CCN2 protein |
CTD |
PMID:31062909 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ces1d |
carboxylesterase 1D |
increases hydrolysis |
ISO |
CES1 protein results in increased hydrolysis of Ramipril |
CTD |
PMID:25445008 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
EXP |
Ramipril results in decreased expression of COL1A1 mRNA |
CTD |
PMID:11851355 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Doxorubicin results in increased phosphorylation of CTNNB1 protein] |
CTD |
PMID:36636964 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
multiple interactions decreases expression |
ISO |
Ramipril inhibits the reaction [Cyclosporine results in increased expression of CYBA mRNA]; Ramipril inhibits the reaction [Tacrolimus results in increased expression of CYBA mRNA] Ramipril results in decreased expression of CYBA mRNA |
CTD |
PMID:12352326 PMID:16891913 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
decreases expression |
ISO |
Ramipril results in decreased expression of CYBB mRNA |
CTD |
PMID:16891913 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Doxorubicin results in increased expression of FN1 protein] |
CTD |
PMID:36636964 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
EXP |
[Streptozocin co-treated with Resveratrol co-treated with Ramipril] results in increased phosphorylation of FOXO3 protein |
CTD |
PMID:31062909 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Carbon Tetrachloride results in increased expression of GOT1 protein] |
CTD |
PMID:26862777 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein] |
CTD |
PMID:26862777 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Doxorubicin results in increased expression of IL1B protein] |
CTD |
PMID:36636964 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Doxorubicin results in increased expression of IL6 protein] |
CTD |
PMID:36636964 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kng1 |
kininogen 1 |
decreases degradation |
EXP |
Ramipril results in decreased degradation of KNG1 protein |
CTD |
PMID:2535056 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Lep |
leptin |
multiple interactions decreases expression |
ISO |
candesartan promotes the reaction [Ramipril results in increased expression of LEP]; Ramipril promotes the reaction [candesartan results in increased expression of LEP] Ramipril results in decreased expression of LEP |
CTD |
PMID:17483542 PMID:19059660 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
[Resveratrol co-treated with Ramipril] inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK8 protein]; Ramipril inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:31062909 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression |
EXP |
Ramipril results in decreased expression of MMP2 mRNA |
CTD |
PMID:11851355 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Myh7 |
myosin heavy chain 7 |
decreases expression multiple interactions |
EXP |
Ramipril results in decreased expression of MYH7 mRNA Ramipril inhibits the reaction [Doxorubicin results in increased expression of MYH7 mRNA] |
CTD |
PMID:15667801 PMID:36636964 |
|
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
EXP |
[Ramipril co-treated with Sodium Chloride deficiency] results in increased expression of NOS1 protein; Metoprolol inhibits the reaction [[Ramipril co-treated with Sodium Chloride deficiency] results in increased expression of NOS1 protein]; Metoprolol inhibits the reaction [Ramipril promotes the reaction [Sodium Chloride deficiency results in increased expression of NOS1 mRNA]]; Ramipril promotes the reaction [Sodium Chloride deficiency results in increased expression of NOS1 mRNA] |
CTD |
PMID:11832429 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions |
ISO |
NOS3 protein affects the reaction [Ramipril results in increased abundance of Cyclic GMP] |
CTD |
PMID:16891913 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppb |
natriuretic peptide B |
decreases expression |
EXP |
Ramipril results in decreased expression of NPPB mRNA |
CTD |
PMID:15667801 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
multiple interactions decreases expression |
ISO |
Ramipril inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PDGFA mRNA] Ramipril results in decreased expression of PDGFA mRNA |
CTD |
PMID:10352363 |
|
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
multiple interactions decreases expression |
ISO |
Ramipril inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PDGFB mRNA] Ramipril results in decreased expression of PDGFB mRNA |
CTD |
PMID:10352363 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[Ramipril co-treated with Sodium Chloride deficiency] results in increased expression of PTGS2 protein; Ramipril promotes the reaction [Sodium Chloride deficiency results in increased expression of PTGS2 mRNA] |
CTD |
PMID:11832429 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ren |
renin |
increases activity increases expression multiple interactions |
ISO EXP |
Ramipril results in increased activity of REN protein Ramipril results in increased expression of REN protein Ramipril inhibits the reaction [Doxorubicin results in increased expression of REN mRNA]; Ramipril inhibits the reaction [Isoproterenol results in increased expression of REN protein]; Ramipril promotes the reaction [Sodium Chloride deficiency results in increased activity of REN protein]; Ramipril promotes the reaction [Sodium Chloride deficiency results in increased expression of REN mRNA] Ramipril results in increased expression of REN mRNA |
CTD |
PMID:1327051 PMID:9179393 PMID:9539862 PMID:11832429 PMID:14504926 PMID:36636964 More...
|
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
EXP |
[Resveratrol co-treated with Ramipril] inhibits the reaction [Streptozocin results in increased expression of RHOA protein]; Ramipril inhibits the reaction [Streptozocin results in increased expression of RHOA protein] |
CTD |
PMID:31062909 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
multiple interactions |
EXP |
[Resveratrol co-treated with Ramipril] inhibits the reaction [Streptozocin results in increased expression of ROCK2 protein]; Ramipril inhibits the reaction [Streptozocin results in increased expression of ROCK2 protein] |
CTD |
PMID:31062909 |
|
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
EXP |
[Streptozocin co-treated with Resveratrol co-treated with Ramipril] results in increased expression of SIRT1 protein |
CTD |
PMID:31062909 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc15a1 |
solute carrier family 15 member 1 |
multiple interactions |
ISO |
Ramipril inhibits the reaction [SLC15A1 protein results in increased uptake of glycylsarcosine] |
CTD |
PMID:18713951 |
|
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
|
|
G |
Slc15a2 |
solute carrier family 15 member 2 |
multiple interactions |
EXP |
Ramipril inhibits the reaction [SLC15A2 protein results in increased uptake of glycylsarcosine] |
CTD |
PMID:18713951 |
|
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions |
EXP |
[Streptozocin co-treated with Resveratrol co-treated with Ramipril] results in decreased phosphorylation of SMAD2 protein |
CTD |
PMID:31062909 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions decreases expression decreases activity |
ISO EXP |
Ramipril inhibits the reaction [Cyclosporine results in increased expression of TGFB1 mRNA]; Ramipril inhibits the reaction [Tacrolimus results in increased expression of TGFB1 mRNA] Ramipril results in decreased expression of TGFB1 mRNA [Streptozocin co-treated with Ramipril] results in increased expression of TGFB1 protein; [Streptozocin co-treated with Resveratrol co-treated with Ramipril] results in increased expression of TGFB1 protein; Ramipril inhibits the reaction [Tacrolimus results in increased expression of TGFB1 protein] Ramipril results in decreased activity of TGFB1 protein |
CTD |
PMID:12352326 PMID:12631109 PMID:15667801 PMID:17703430 PMID:20551625 PMID:31062909 More...
|
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfbr3 |
transforming growth factor beta receptor 3 |
multiple interactions |
EXP |
[Streptozocin co-treated with Resveratrol co-treated with Ramipril] results in decreased expression of TGFBR3 protein |
CTD |
PMID:31062909 |
|
NCBI chr14:2,489,397...2,665,383
Ensembl chr14:2,489,397...2,663,341
|
|
G |
Timp4 |
TIMP metallopeptidase inhibitor 4 |
increases expression |
EXP |
Ramipril results in increased expression of TIMP4 mRNA |
CTD |
PMID:11851355 |
|
NCBI chr 4:148,306,021...148,312,558
Ensembl chr 4:148,304,490...148,312,558
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Doxorubicin results in increased expression of TNF protein] |
CTD |
PMID:36636964 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Wnt3a |
Wnt family member 3A |
multiple interactions |
EXP |
Ramipril inhibits the reaction [Doxorubicin results in increased expression of WNT3A protein] |
CTD |
PMID:36636964 |
|
NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
|
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
increases response to substance |
ISO |
BDKRB2 results in increased susceptibility to ramiprilat |
CTD |
PMID:10523327 |
|
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Kng1 |
kininogen 1 |
decreases degradation |
EXP |
ramiprilat results in decreased degradation of KNG1 protein |
CTD |
PMID:2535056 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
telaprevir inhibits the reaction [CYP3A4 protein results in increased metabolism of Simvastatin] |
CTD |
PMID:24927617 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|